Tavel, Jorge A <br/><br/>
Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study.  [electronic resource] 

 -  PloS one  Feb 2010 
 - e9334 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0009334  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--adverse effects<br/>Atazanavir Sulfate<br/>CD4 Lymphocyte Count<br/>Carbamates--therapeutic use<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Fever--chemically induced<br/>Furans<br/>HIV Infections--drug therapy<br/>Humans<br/>Interleukin-2--adverse effects<br/>Lopinavir<br/>Male<br/>Nausea--chemically induced<br/>Oligopeptides--therapeutic use<br/>Opportunistic Infections--chemically induced<br/>Organophosphates--therapeutic use<br/>Pyridines--therapeutic use<br/>Pyrimidinones--therapeutic use<br/>Ritonavir--therapeutic use<br/>Sulfonamides--therapeutic use<br/>Treatment Outcome